Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Pitts

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Vaccine|August 8, 2023
Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization ratesPeter J Pitts, Gregory A Poland
Vaccine|November 29, 2024
Addressing vaccine misinformation: The critical need for complete product information disclosurePeter J Pitts, Gregory A Poland
Vaccine|April 11, 2024
Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemicPeter J Pitts, Gregory A Poland
Therapeutic Innovation & Regulatory Science|May 2, 2018
Advancing Drug Safety Through Prospective PharmacovigilancePeter J Pitts, Hervé Le Louet
Therapeutic Innovation & Regulatory Science|August 11, 2022
Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated ActionHervé Le Louët, Peter J Pitts
Blockchain in Healthcare Today|February 25, 2025
Healthcare Futures: Opportunities, Challenges and Risks in a Blockchain-Driven EnvironmentRobert Goldberg, Peter J Pitts, Jennifer Hinkel
Therapeutic Innovation & Regulatory Science|November 6, 2018
21st-Century Oncology Drug Safety via New-Age Regulatory Standards and PracticesPeter J Pitts, Hervé Le Louet, Gregory Katz
Vaccine|February 1, 2026
COVID-19 vaccine policy: a response and way forwardGregory A Poland, Tamar Ratishvili, Peter J Pitts
Therapeutic Innovation & Regulatory Science|July 21, 2025
Transforming Objective Participatory Patient AdvocacyPat Furlong, Timothy R Franson, Peter J Pitts
Saudi Medical Journal|November 24, 2015
A qualitative exploration of the major challenges facing pharmacovigilance in Saudi ArabiaP Ravi Shankar, Nisha Jha, Hisham Aljadhey, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Vaccine|August 8, 2023
Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization ratesPeter J Pitts, Gregory A Poland
Vaccine|November 29, 2024
Addressing vaccine misinformation: The critical need for complete product information disclosurePeter J Pitts, Gregory A Poland
Vaccine|April 11, 2024
Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemicPeter J Pitts, Gregory A Poland
Therapeutic Innovation & Regulatory Science|May 2, 2018
Advancing Drug Safety Through Prospective PharmacovigilancePeter J Pitts, Hervé Le Louet
Therapeutic Innovation & Regulatory Science|August 11, 2022
Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated ActionHervé Le Louët, Peter J Pitts
Blockchain in Healthcare Today|February 25, 2025
Healthcare Futures: Opportunities, Challenges and Risks in a Blockchain-Driven EnvironmentRobert Goldberg, Peter J Pitts, Jennifer Hinkel
Therapeutic Innovation & Regulatory Science|November 6, 2018
21st-Century Oncology Drug Safety via New-Age Regulatory Standards and PracticesPeter J Pitts, Hervé Le Louet, Gregory Katz
Vaccine|February 1, 2026
COVID-19 vaccine policy: a response and way forwardGregory A Poland, Tamar Ratishvili, Peter J Pitts
Therapeutic Innovation & Regulatory Science|July 21, 2025
Transforming Objective Participatory Patient AdvocacyPat Furlong, Timothy R Franson, Peter J Pitts
Saudi Medical Journal|November 24, 2015
A qualitative exploration of the major challenges facing pharmacovigilance in Saudi ArabiaP Ravi Shankar, Nisha Jha, Hisham Aljadhey, et al.
Pageof 4